Fleury (BSP:FLRY3) Other Operating Expense: R$901 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:FLRY3 Fleury SA BSP:FLRY3
90 GF Score
Price R$16.42
GF Value R$17.49
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Fleury Other Operating Expense?

Fleury BSP:FLRY3 -0.55% 90 Other Operating Expense is R$901 Mil as of Mar. 2026. GuruFocus rates BSP:FLRY3 with a GF Score™ of 90/100 and a GF Value™ of R$17.49 (Fairly Valued). The stock has 5 warning signs investors should review.

Fleury's Other Operating Expense for the three months ended in Mar. 2026 was R$183 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was R$901 Mil.

Fleury's quarterly Other Operating Expense increased from Sep. 2025 (R$7 Mil) to Dec. 2025 (R$705 Mil) but then declined from Dec. 2025 (R$705 Mil) to Mar. 2026 (R$183 Mil).

Fleury's annual Other Operating Expense increased from Dec. 2023 (R$556 Mil) to Dec. 2024 (R$657 Mil) and increased from Dec. 2024 (R$657 Mil) to Dec. 2025 (R$721 Mil).


Fleury Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Fleury's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fleury Other Operating Expense Chart

Fleury Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 344.70 328.96 555.87 656.53 720.54

Fleury Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 176.56 5.17 7.32 705.23 183.32
BSP:FLRY3
90GF Score
Fleury SA BSP:FLRY3
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fleury Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$901 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of R$901 Mil mean?
Fleury (BSP:FLRY3) has a Other Operating Expense of R$901 Mil as of Mar. 2026. Other operating expenses that a company records on its income statement. View historical data on Fleury and its competitors.
Is Fleury's Other Operating Expense too high?
Fleury's current Other Operating Expense is R$901 Mil. Overall, Fleury has a GF Score™ of 90/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fleury's Other Operating Expense compare to TMO and DHR?
Fleury's Other Operating Expense of R$901 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Medical Diagnostics & Research company?
A good Other Operating Expense depends on the Medical Diagnostics & Research industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Fleury and its competitors. Fleury's current Other Operating Expense is R$901 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fleury stock overvalued right now?
Based on GuruFocus' analysis, Fleury (BSP:FLRY3) is currently considered Fairly Valued. The stock's GF Value™ is R$17.49, compared to a current price of R$16.42 — trading 6.1% below its estimated fair value. The current Other Operating Expense is R$901 Mil. Fleury's overall GF Score™ is 90/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Fleury (BSP:FLRY3), the current Other Operating Expense is R$901 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fleury (BSP:FLRY3) Overvalued in 2026?

Based on GuruFocus' analysis, Fleury stock appears to be undervalued. The current stock price of R$16.42 is trading 6.1% below its estimated GF Value™ of R$17.49. GuruFocus considers Fleury to be Fairly Valued.

Key valuation signals for BSP:FLRY3:

  • Other Operating Expense: R$901 Mil
  • GF Value™: R$17.49 vs. price of R$16.42 (6.1% below fair value)
  • GF Score™: 90/100 with 5 warning signs

No single metric tells the full story. See the BSP:FLRY3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Fleury Business Description

Address Avenida Morumbi 8.860, 8th floor, Brooklin, Sao Paulo, SP, BRA, 04703-002
Fleury SA is engaged in the provision of medical services in the diagnostic, laboratory support (Lab-to-Lab), infusions, clinical analysis, health management, medical care, orthopedics and ophthalmology, fertility, infusion areas and toxicological exams, among others. The company offers diagnostic medicine through physical service units and mobile diagnostic services for consumers. It also provides diagnostic support services to laboratories and hospitals. In addition, the company operates clinics and services in areas such as infusion therapy, orthopedics, ophthalmology, reproductive medicine, and oncology. It has two reportable business segments: Diagnostic Medicine and Integrated Medicine. The maximum revenue is generated from the Diagnostic Medicine Segment.
90GF Score

Get the complete analysis for BSP:FLRY3

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$16.42
Price
R$17.49
GF Value